Skip to content

Neupulse
NON-INVASIVE AND DRUG FREE

Pre-order Neupulse C

Only available in the UK | Delivery estimate September 2026

Discover Neupulse C

What is Neupulse C?

Through gentle, non-invasive stimulation, Neupulse C is a wearable device designed to support calm and relaxation during moments of restlessness or physical tension, helping you feel more at ease and in control.

Drug free & non-invasive

Support should fit around who you are. Neupulse C is designed to support your wellbeing without disruption to your day.

You're in control

Designed to fit around your life, Neupulse C can be used whenever you choose, giving you support on your terms.

Backed by science

Neupulse C technology is informed by decades of neuroscience research, bringing this knowledge into a wearable designed for everyday wellbeing.

Our approach

For years, our focus has been on developing a medical device grounded in neuroscience research. As that work progresses through regulatory approval, we’re launching a wellness device bringing the same technology into everyday use - making it accessible, sooner.

Testimonials

How people describe their experience with Neupulse

Anonymous

UK User

“I felt a wave, like a wave of calm over my body.”

Anonymous

UK User

"The stimulation is relaxing. It definitely makes me relaxed.”

Anonymous

UK User

"It was a positive feeling, I felt calm.”

Anonymous

UK User

"It feels good. The stimulation feels relaxing.”​

Individual experiences may vary.

Getting started

1. Order the Neupulse C device

Register Now

2. Download the Neutrack C App

Coming Soon
Neupulse

Our clinical work continues

Alongside our wellness device and based on the same underlying technology, our clinical device is currently progressing through regulatory approval.

Learn more

Frequently Asked Questions

Here are the answers to your most asked questions.

You can find more answers on our FAQ page or get in touch via our contact page. We are here to help.

Our FAQs

When will the device be available?

We are planning our Great Britain (England, Scotland, Wales) release in 2026, with the US, Europe, and beyond to follow as soon as we gain regulatory approval in each territory. Sign up to our newsletter to keep up to date on developments.